This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]

  • Nucleotide binding
  • Enables protein kinase activity
  • Protein serine/threonine/tyrosine kinase activity
  • Protein tyrosine kinase activity
  • Enables transmembrane receptor protein tyrosine kinase activity
  • Located in nucleus
  • Located in nucleoplasm
  • Located in cytoplasm
  • Located in endoplasmic reticulum membrane
  • Located in Golgi apparatus
  • Involved in luteinization
  • Involved in in utero embryonic development
  • Involved in cell activation
  • Involved in hematopoietic progenitor cell differentiation
  • Protein phosphorylation

Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands – homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor.

  • Sunitinib
  • Imatinib
  • Pazopanib
  • Olaratumab
  • Regorafenib
  • Nintedanib
  • D-Tyrosine
  • Avapritinib
  • Becaplermin
  • Lenvatinib
  • Midostaurin
  • Ponatinib
  • Ripretinib
  • Erdafitinib
  • Foreskin keratinocyte (neonatal)
  • Fostamatinib
  • Tivozanib
  • Axitinib
  • Carboplatin
  • Dasatinib
  • Gefitinib
  • Nilotinib
  • Paclitaxel
  • Rabeprazole
  • Ramuciruma
  • Romiplostim
  • Sorafenib
  • Vandetanib
  • Autosomal dominant inheritance
  • Abnormal liver morphology
  • Abnormality of the nervous system
  • Abnormality of the skin
  • Hyperpigmentation of the skin
  • Skin rash
  • Pruritus
  • Abnormality of skin pigmentation
  • Abnormality of the liver
  • Somatic mutation
  • Abnormal abdomen morphology
  • Abnormality of the integument
  • Abnormality of the cardiovascular system
  • Abnormal heart morphology
  • Abnormal myocardium morphology
  • Cardiomyopathy
  • Restrictive cardiomyopathy
  • Abnormality of the spleen
  • Splenomegaly
  • Abnormality of blood and blood-forming tissues

PDGFRA Localizations – Subcellular Localization Database

This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]

  • Nucleotide binding
  • Enables protein kinase activity
  • Protein serine/threonine/tyrosine kinase activity
  • Protein tyrosine kinase activity
  • Enables transmembrane receptor protein tyrosine kinase activity
  • Located in nucleus
  • Located in nucleoplasm
  • Located in cytoplasm
  • Located in endoplasmic reticulum membrane
  • Located in Golgi apparatus
  • Involved in luteinization
  • Involved in in utero embryonic development
  • Involved in cell activation
  • Involved in hematopoietic progenitor cell differentiation
  • Protein phosphorylation

Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands – homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor.

  • Sunitinib
  • Imatinib
  • Pazopanib
  • Olaratumab
  • Regorafenib
  • Nintedanib
  • D-Tyrosine
  • Avapritinib
  • Becaplermin
  • Lenvatinib
  • Midostaurin
  • Ponatinib
  • Ripretinib
  • Erdafitinib
  • Foreskin keratinocyte (neonatal)
  • Fostamatinib
  • Tivozanib
  • Axitinib
  • Carboplatin
  • Dasatinib
  • Gefitinib
  • Nilotinib
  • Paclitaxel
  • Rabeprazole
  • Ramuciruma
  • Romiplostim
  • Sorafenib
  • Vandetanib
  • Autosomal dominant inheritance
  • Abnormal liver morphology
  • Abnormality of the nervous system
  • Abnormality of the skin
  • Hyperpigmentation of the skin
  • Skin rash
  • Pruritus
  • Abnormality of skin pigmentation
  • Abnormality of the liver
  • Somatic mutation
  • Abnormal abdomen morphology
  • Abnormality of the integument
  • Abnormality of the cardiovascular system
  • Abnormal heart morphology
  • Abnormal myocardium morphology
  • Cardiomyopathy
  • Restrictive cardiomyopathy
  • Abnormality of the spleen
  • Splenomegaly
  • Abnormality of blood and blood-forming tissues

PDGFRA Localizations – Subcellular Localization Database